ECM2 Polyclonal antibody

ECM2 Polyclonal Antibody for IF, IHC, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human, mouse, rat

Applications

WB, IHC, IF, ELISA

Conjugate

Unconjugated

Cat no : 21376-1-AP

Synonyms

ECM2, Extracellular matrix protein 2, Matrix glycoprotein SC1, Matrix glycoprotein SC1/ECM2



Tested Applications

Positive IHC detected inmouse cerebellum tissue, human ovary tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Positive IF detected inL02 cells

Recommended dilution

ApplicationDilution
Immunohistochemistry (IHC)IHC : 1:50-1:500
Immunofluorescence (IF)IF : 1:20-1:200
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

The immunogen of 21376-1-AP is ECM2 Fusion Protein expressed in E. coli.

Tested Reactivity human, mouse, rat
Cited Reactivityhuman
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen ECM2 fusion protein Ag15913
Full Name extracellular matrix protein 2, female organ and adipocyte specific
Calculated Molecular Weight 699 aa, 80 kDa
GenBank Accession NumberBC107493
Gene Symbol ECM2
Gene ID (NCBI) 1842
RRIDAB_2878850
Conjugate Unconjugated
Form Liquid
Purification MethodAntigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Protocols

Product Specific Protocols
IHC protocol for ECM2 antibody 21376-1-APDownload protocol
IF protocol for ECM2 antibody 21376-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
humanWB

Mol Neuropsychiatry

Cell Type-Specific Effects of Mutant DISC1: A Proteomics Study.

Authors - Meng Xia
humanIHC

Int J Biochem Cell Biol

ECM2, a prognostic biomarker for lower grade glioma, serves as a potential novel target for immunotherapy

Authors - Xingbo Cheng